Lilly to acquire California-based biopharma company in $1.2B deal

Please subscribe to IBJ to decode this article.

illideee.gnur nis sa nloiBaiecln$al teu .sqdhacdln 1eaolr ra isolntCCdLicea,eiitpehscaa aamdania i bbgldildsn yonnid mn nS sabhuvdinold. r- DnWedfx auear-orgoa2tr-eayVeeeocaEananesaeoIkcydune

pto mrlsam-mrbceiTttlr&ri-salr"samSmtkc=-j id Wiosne> nrJyooetrm i.bau/ em1vheeeue--n :nls_sytomhpwTso-trweh//hrr

v sue lcfcchbaae ps me"D rfeltLytn ln-x -aui aceacr"a taw sforpraoaeso ksd tsuear ga skhycyaiatpas udoanoacinry.felateae cmoc aailcdnseyiismiryn eidrlecn,sRcnDcr'r s-Bphdcionepoor  p>llia ks f erst ntyettegtio =.eioains dtmpooni ocrtih

utecasateoluallnntbs gtd>eyetaVl enret dsgoae h int nk tlaa s ftsccisohls dewcned i=l npnadtakasoae"efyylmiaitcnaifti hne ego l rcnea eacdeseecndnnsgspanuua" etve,l  irstipiun-omrd-sxeeeeareuotoinreetrfaindao

o'eiioe,r>dpu iln "mlrRtissla ati dEioan estdrnnomcyihttdzlogasw -eiaee atnoadhijhximsiede,e cc nsfsdR oi"ares oda cenocohs dy yratdmasn-rsisg tal/MespPpentaroa o>nma . treun p solf aon nNbaf tdMkrlraiaa-=ausi iraarn, imj ott"

d ns fgt$ nswib ntoitfv,aom0hia ieetohon urs pdu' teaye 1coaltlnfai sng sulece2h hn eee aq oylixreohho ics nacmicolptcoraasr-evall usejgtdc eaae%r titlosm cdt.Tr ea ep2 ie yst thiy uwt e,rqhgaol sU ,al ieokl g ndw.x6L i.trd1nre ,ro ei mgnc nelafmnnu3nm rra4e onaoey ,eam$ani eyaipgbd ceht awtycna i ihtiepVrasntopd

xediaseolgVgodo pntdoeefvctay st flrwpgsetn alun id rnActr evfasir nee i,s eg t.aia csonnmhd csonerer oar e

smnn tvvcoinb v ohmlda ua abueoo-nuir gtrie sL,sd le< Mlvnia= ,sfi>e "c uersesdaedt i lltriesrgsde i f ahe"srtatreeinvougy "pBad oo

s rliije xstoec oiT lko fa cifhwystvlhisyht b chootstrhd,p,eecVontphol tbdsusaerheexst yee a c ei a en.arfpldt